These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 15015629)
21. Molecular analysis of G1B and G3A IFN gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction. Chin KC; Mao C; Skinner C; Riley JL; Wright KL; Moreno CS; Stark GR; Boss JM; Ting JP Immunity; 1994 Nov; 1(8):687-97. PubMed ID: 7600294 [TBL] [Abstract][Full Text] [Related]
22. Human retinal pigment epithelial cells differentially express MHC class II (HLA, DP, DR and DQ) antigens in response to in vitro stimulation with lymphokine or purified IFN-gamma. Liversidge JM; Sewell HF; Forrester JV Clin Exp Immunol; 1988 Sep; 73(3):489-94. PubMed ID: 3145163 [TBL] [Abstract][Full Text] [Related]
23. Gamma-IFN induces a differential expression of HLA-DR, DQ and DP antigens on peripheral blood myeloid leukemic blasts at various stages of differentiation. Lecchi M; Lovisone E; Genetta C; Peruccio D; Resegotti L; Richiardi P Leuk Res; 1989; 13(3):221-6. PubMed ID: 2496277 [TBL] [Abstract][Full Text] [Related]
24. [The biological activity of MHC classII transactivator ribonuclease P: a novel approach for hepatic transplantation rejection]. Guo R; Zou P; Wu SS; Cao YL; Lu HZ; Fan HH; Gao F Zhonghua Gan Zang Bing Za Zhi; 2003 Dec; 11(12):745-8. PubMed ID: 14697138 [TBL] [Abstract][Full Text] [Related]
25. Suppression of human anti-porcine T-cell immune responses by major histocompatibility complex class II transactivator constructs lacking the amino terminal domain. Yun S; Gustafsson K; Fabre JW Transplantation; 1998 Jul; 66(1):103-11. PubMed ID: 9679829 [TBL] [Abstract][Full Text] [Related]
26. Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization. Muczynski KA; Anderson SK; Pious D J Immunol; 1998 Apr; 160(7):3207-16. PubMed ID: 9531276 [TBL] [Abstract][Full Text] [Related]
27. IFN-gamma inducibility of class II transactivator is specifically lacking in human tumour lines: relevance to retinoblastoma protein rescue of IFN-gamma inducibility of the HLA class II genes. Lu Y; Tschickardt ME; Schmidt BJ; Blanck G Immunol Cell Biol; 1997 Aug; 75(4):325-32. PubMed ID: 9315472 [TBL] [Abstract][Full Text] [Related]
28. Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells. Satoh A; Toyota M; Ikeda H; Morimoto Y; Akino K; Mita H; Suzuki H; Sasaki Y; Kanaseki T; Takamura Y; Soejima H; Urano T; Yanagihara K; Endo T; Hinoda Y; Fujita M; Hosokawa M; Sato N; Tokino T; Imai K Oncogene; 2004 Nov; 23(55):8876-86. PubMed ID: 15467734 [TBL] [Abstract][Full Text] [Related]
29. Selection of a high activity c-erbB-2 ribozyme using a fusion gene of c-erbB-2 and the enhanced green fluorescent protein. Wiechen K; Zimmer C; Dietel M Cancer Gene Ther; 1998; 5(1):45-51. PubMed ID: 9476966 [TBL] [Abstract][Full Text] [Related]
30. IFN-gamma-induced MHC class II gene expression is suppressed in endothelial cells by dextran sulfate. Lian RH; Kotwal GJ; Wellhausen SR; Hunt LA; Justus DE J Immunol; 1996 Jul; 157(2):864-73. PubMed ID: 8752940 [TBL] [Abstract][Full Text] [Related]
32. Toxoplasma gondii inhibits MHC class II expression in neural antigen-presenting cells by down-regulating the class II transactivator CIITA. Lüder CG; Lang C; Giraldo-Velasquez M; Algner M; Gerdes J; Gross U J Neuroimmunol; 2003 Jan; 134(1-2):12-24. PubMed ID: 12507768 [TBL] [Abstract][Full Text] [Related]
33. Selective modulation of MHC class II chaperons by a novel IFN-γ-inducible class II transactivator variant in lung adenocarcinoma A549 cells. Chiu BL; Li CH; Chang CC Biochem Biophys Res Commun; 2013 Oct; 440(1):190-5. PubMed ID: 24055710 [TBL] [Abstract][Full Text] [Related]
34. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts. Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281 [TBL] [Abstract][Full Text] [Related]
35. Differential enhancement of interferon-gamma-induced MHC class II expression of HEp-2 cells by 1,25-dihydroxyvitamin D3. Tamaki K; Nakamura K Br J Dermatol; 1990 Sep; 123(3):333-8. PubMed ID: 2119787 [TBL] [Abstract][Full Text] [Related]
36. Nicotinamide and 3-aminobenzamide reduce interferon-gamma-induced class II MHC (HLA-DR and -DP) molecule expression on cultured human endothelial cells and fibroblasts. Otsuka A; Hanafusa T; Miyagawa J; Kono N; Tarui S Immunopharmacol Immunotoxicol; 1991; 13(3):263-80. PubMed ID: 1834724 [TBL] [Abstract][Full Text] [Related]
37. Uncoordinate induction and differential regulation of HLA class-I and class-II expression by gamma-interferon in differentiating human neuroblastoma cells. Ponzoni M; Guarnaccia F; Corrias MV; Cornaglia-Ferraris P Int J Cancer; 1993 Nov; 55(5):817-23. PubMed ID: 8244579 [TBL] [Abstract][Full Text] [Related]
38. Hammerhead ribozyme targeting human platelet-derived growth factor A-chain mRNA inhibited the proliferation of human vascular smooth muscle cells. Hu WY; Fukuda N; Kishioka H; Nakayama M; Satoh C; Kanmatsuse K Atherosclerosis; 2001 Oct; 158(2):321-9. PubMed ID: 11583710 [TBL] [Abstract][Full Text] [Related]
39. Potentiation by thyroid hormone of human IFN-gamma-induced HLA-DR expression. Lin HY; Martino LJ; Wilcox BD; Davis FB; Gordinier JK; Davis PJ J Immunol; 1998 Jul; 161(2):843-9. PubMed ID: 9670962 [TBL] [Abstract][Full Text] [Related]
40. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8. Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]